AAQ1 — aap Implantate AG Cashflow Statement
0.000.00%
Last trade - 00:00- €24.72m
- €23.67m
- €12.49m
Annual cashflow statement for aap Implantate AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.52 | -2.56 | -7.96 | -3.63 | -2.58 |
| Depreciation | |||||
| Non-Cash Items | 0.045 | -0.816 | 0.197 | 0.721 | -0.031 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.84 | -0.185 | 0.782 | -0.077 | -0.686 |
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.47 | -1.89 | -2.91 | -1.12 | -1.43 |
| Capital Expenditures | -0.523 | -0.485 | -0.406 | -0.33 | -0.725 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.678 | 0.016 | 0.019 | 0.003 | 0.055 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.155 | -0.469 | -0.387 | -0.327 | -0.67 |
| Financing Cash Flow Items | -0.321 | -0.249 | -0.328 | -0.168 | -0.063 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.53 | 0.475 | 4.34 | 2.22 | 0.859 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.23 | -1.88 | 1.04 | 0.753 | -1.41 |